Company Description

Aethlon Medical, Inc., a medical therapeutic company, engages in developing novel immunotherapeutic devices to treat cancer and viral infections in the United States.

It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation.

The company was founded in 1984 and is based in San Diego, California.

Aethlon Medical, Inc.

Country	United States
Founded	1984
Industry	Medical Devices
Sector	Healthcare
Employees	9
CEO	James Frakes

Contact Details

Address: 11555 Sorrento Valley Road, Suite 203 San Diego, California 92121 United States
Phone	619 941 0360
Website	aethlonmedical.com

Stock Details

Ticker Symbol	AEMD
Exchange	NASDAQ
Stock Type	Common Stock
Fiscal Year	April - March
Reporting Currency	USD
CIK Code	0000882291
CUSIP Number	00808Y505
ISIN Number	US00808Y5050
Employer ID	13-3632859
SIC Code	3841

Key Executives

Name	Position
James B. Frakes M.B.A.	Chief Executive Officer, Chief Financial Officer, Chief Accounting Officer, Secretary and Director
Guy F. Cipriani BS (Eng.), MBA	Senior Vice President and Chief Operating Officer
Dr. Steven P. LaRosa M.D.	Chief Medical Officer
Michele Bombardiere	Vice President and Controller

Latest SEC Filings

Date	Type	Title
Sep 22, 2025	SCHEDULE 13G	Filing
Sep 12, 2025	8-K	Current Report
Sep 10, 2025	SCHEDULE 13G	Filing
Sep 9, 2025	8-K	Current Report
Sep 5, 2025	424B4	Prospectus
Sep 4, 2025	EFFECT	Notice of Effectiveness
Aug 29, 2025	S-1/A	[Amend] General form for registration of securities under the Securities Act of 1933
Aug 21, 2025	8-K	Current Report
Aug 20, 2025	S-1	General form for registration of securities under the Securities Act of 1933
Aug 20, 2025	1-A-W	Filing

View All SEC Filings